Liver Biopsy Assessment in Chronic Hepatitis

Archives of Medical Research

Volumn 38, Issue 6, 2007, Pages 634-643

  Lefkowitch, Jay H ^a  

^a Columbia University ^*  (United States)

Author keywords

Chronic hepatitis; Histopathological methods; Liver biopsy

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

CHRONIC HEPATITIS; DISEASE CLASSIFICATION; DYSPLASIA; EFFECTOR CELL; GENOTYPE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY CELL; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NECROSIS; PROTEIN EXPRESSION; REVIEW; SCORING SYSTEM; STEATOSIS; T LYMPHOCYTE; VIRUS HEPATITIS; VIRUS INTERFERENCE; VIRUS REPLICATION;

BIOPSY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS;

EID: 34347257433     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.08.005     Document Type: Review

References (51)

1. Menghini G. One-second needle biopsy of the liver. Gastroenterology 35 (1958) 190-199
2. Diseases of the Liver and Biliary Tract. Standardization of Nomenclature, Diagnostic Criteria, and Diagnostic Methodology (1976), U.S. Government Printing Office, Washington, DC p. 9
3. Poynard T., McHutchison J., Manns M., Myers R.P., and Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 38 (2003) 481-492
4. Colletta C., Smirne C., Fabris C., Toniutto P., Rapetti R., Minisini R., et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 42 (2005) 838-845
5. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
6. Ghany M.G., and Doo E. Assessment of liver fibrosis: palpate, poke or pulse?. Hepatology 42 (2005) 759-761
7. Almasio P.L., Niero M., Angioli D., Ascione A., Gullini S., Minoli G., et al. Experts' opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.). J Hepatol 43 (2005) 381-387
8. Saitou Y., Shiraki K., Fuke H., Inoue T., Miyashita K., Yamanaka Y., et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Hum Pathol 36 (2005) 1066-1073
9. Roskams T. Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus. J Hepatol 39 (2003) 431-434
10. Eleazar J.A., Memeo L., Jhang J.S., Mansukhani M.M., Chin S., Park S.M., et al. Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis. J Hepatol 41 (2005) 983-991
11. Ramadori G., and Saile B. Portal tract fibrogenesis in the liver. Lab Invest 84 (2004) 153-159
12. Clouston A.D., Powell E.E., Walsh M.J., Richardson M.M., Demetris A.J., and Jonsson J.R. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 41 (2005) 809-818
13. Tanji K., Bhagat G., Vu T.H., Monzon L., Bonilla E., and Lefkowitch J.H. Mitochondrial DNA dysfunction in oncocytic hepatocytes. Liver Int 23 (2003) 397-403
14. Lefkowitch J.H., Arbörgh B.M., and Scheuer P.J. Oxyphilic granular hepatocytes. Mitochondrion-rich liver cells in hepatic disease. Am J Clin Pathol 74 (1980) 432-441
15. Chen T.-J., and Liaw Y.-F. The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis: a histopathologic study. Liver 8 (1988) 10-16
16. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., and Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19 (1994) 1513-1520
17. Popper H., and Schaffner F. The vocabulary of chronic hepatitis. N Engl J Med 284 (1971) 1154-1156
18. Lazzarini A.L., Levine R.A., Ploutz-Snyder R.J., and Sanderson S.O. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int 25 (2005) 1142-1149
19. Hoofring A., Boitnott J., and Torbenson M. Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection. J Hepatol 39 (2003) 738-741
20. Desmet V.J., and Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 40 (2004) 860-867
21. Lemasters J.J. Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis. Gastroenterology 129 (2005) 351-360
22. Kerr J.F., Cooksley W.G., Searle J., Halliday J.W., Halliday W.J., Holder L., et al. The nature of piecemeal necrosis in chronic active hepatitis. Lancet 20 2 (1979) 827-828
23. Scheuer P.J., Ashrafzadeh P., Sherlock S., Brown D., and Dusheiko G.M. The pathology of hepatitis C. Hepatology 15 (1992) 567-571
24. Phillips M.J., Cameron R., Flowers M.A., Blendis L.M., Greig P.D., Wanless I., et al. Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B. Am J Pathol 140 (1992) 1295-1308
25. Davies S.E., Portmann B.C., O'Grady J.G., Aldis P.M., Chaggar K., Alexander G.J., et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13 (1991) 150-157
26. Anthony P.P., Vogel C.L., and Barker L.F. Liver cell dysplasia: a premalignant condition. J Clin Pathol 26 (1973) 217-223
27. Watanabe S., Okita K., Harada T., Kodama T., Numa Y., Takemoto T., et al. Morphologic studies of the liver cell dysplasia. Cancer 51 (1983) 2197-2205
28. Bianchi L., and Gudat F. Sanded nuclei in hepatitis B: eosinohilic inclusions in liver cell nuclei due to excess in hepatitis B core antigen formation. Lab Invest 35 (1976) 1-5
29. Popper H., Thung S.N., McMahon B.J., Lanier A.P., Hawkins I., and Alberts S.R. Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan eskimos. Arch Pathol Lab Med 112 (1988) 498-504
30. Ter Borg F., Ten Kate F.J., Cuypers H.T., Leentvaar-Kuijpers A., Oosting J., Wertheim-van Dillen P.M., et al. A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals. J Clin Pathol 53 (2000) 541-548
31. Kumar D., Farrell G.C., Fung C., and George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response. Hepatology 36 (2002) 1266-1272
32. Negro F. Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always. Hepatology 36 (2002) 1050-1052
33. Rubbia-Brandt L., Leandro G., Spahr L., Giostra E., Quadri R., Male P.J., et al. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 39 (2001) 119-124
34. Abid K., Pazienza V., de Gottardi A., Rubbia-Brandt L., Conne B., Pugnale P., et al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol 42 (2005) 744-751
35. Gordon F.D., Pomfret E.A., Pomposelli J.J., Lewis W.D., Jenkins R.L., and Khettry U. Severe steatosis as the initial histologic manifestation of recurrent hepatitis C genotype 3. Hum Pathol 35 (2004) 636-638
36. Monto A., Alonzo J., Watson J.J., Grunfeld C., and Wright T.L. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 36 (2002) 729-736
37. Saxena R., Crawford J.M., Navarro V.J., Friedman A.L., and Robert M.E. Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation. Modern Pathol 15 (2002) 897-903
38. Brunt E.M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31 (2000) 241-246
39. De Groote J., Desmet V.J., Gedigk P., Korb G., Popper H., Poulsen H., et al. A classification of chronic hepatitis. Lancet 2 (1968) 626-628
40. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 (1981) 431-435
41. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (1991) 372-374
42. Batts K.P., and Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 (1995) 1409-1417
43. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
44. Bedossa P., Poynard T., and the METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24 (1996) 289-293
45. Bedossa P., Bioulac-Sage P., Callard P., et al. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20 (1994) 15-20
46. Guido M., and Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 24 (2004) 89-97
47. Demetris A.J., and Ruppert K. Pathologist's perspective on liver needle biopsy size?. J Hepatol 39 (2003) 275-277
48. Colloredo G., Guido M., Sonzogni A., and Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39 (2003) 239-244
49. Rousselet M.C., Michalak S., Dupre F., Croue A., Bedossa P., Saint-Andre J.P., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 (2005) 257-264
50. Spangenberg H.C., Viazov S., Kersting N., Neumann-Haefelin C., McKinney D., Roggendorf M., et al. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42 (2005) 828-837
51. Marshall A., Rushbrook S., Davies S.E., Morris L.S., Scott I.S., Vowler S.L., et al. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 128 (2005) 33-42